Hutch News

Stories tagged 'Pancreatic Cancer'

Good News at Fred Hutch

Celebrating faculty and staff achievements

May 4, 2017

First extensive immune profiling of sarcomas shows some types may be susceptible to immunotherapy; Fred Hutch hosts first-of-its-kind regional conference for science communicators; and Pathway that regulates organ size may also underlie tumors’ resistance to certain chemotherapy drugs.

View story >


Dissolving implant could bring immunotherapy to solid tumors

A biopolymer sponge delivers cancer-shrinking T-cell therapy in preclinical study

April 24, 2017 | By Sabrina Richards / Fred Hutch News Service

A dissolving scaffold developed by Dr. Matthias Stephan delivers engineered anti-tumor immune cells to crowded masses of tumor cells and recruits the native immune system to mount a second-wave attack on the cancer.

View story >


Finding ways to deliver on the promise of precision oncology

‘Functional genomics’ method aims to marry three powerful techniques to speed personalized cancer treatments to patients

March 31, 2017 | By Rachel Tompa / Fred Hutch News Service

Dr. Christopher Kemp is confident that the answer to personalized cancer treatment is written in the molecules inside each patient’s tumor, we just need to figure out how to separate the wheat from the chaff.

View story >


A Q&A with Fred Hutch postdoctoral research fellow Dr. Rachel Perret

As part of a world-class immunotherapy research team, Perret is working her ‘dream job’ — trying to bring T-cell therapy to all who need it

Jan. 9, 2017 | By Rachel Tompa / Fred Hutch News Service

A postdoctoral research fellow training under the mentorship of immunotherapy expert Dr. Phil Greenberg, Dr. Rachel Perret is working toward an “off-the-shelf” version of T-cell therapy.

View story >


So you're BRCA, now what?

A Fred Hutch researcher and breast cancer survivor talks about her inherited mutation and how it helped guide her decisions

Nov. 8, 2016 | By Diane Mapes / Fred Hutch News Service

As research sheds ever more light on hereditary cancers and the genes that cause them, a portion of the population is being faced with some very difficult choices. Do you test or not test? Share information about deadly mutations with relatives or keep it to yourself? Get preventive surgery or blindly hope cancer doesn’t strike? A Fred Hutch researcher, BRCA carrier and cancer survivor, takes us through her decision-making process.

View story >


A new model for pancreatic cancer clinical research

Flexible, precision-medicine trial ‘driven by doing what is best for the individual patient’

Oct. 4, 2016 | By Susan Keown / Fred Hutch News Service

Called “Precision Promise,” this new nationwide precision-medicine trial in pancreatic cancer seeks to turn the concept of clinical trials on its head: Rather than finding participants for a given experimental treatment study, the approach finds the right treatment for a given patient at a given time.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.